Business
Vistagen Therapeutics Inc (NASDAQ: VTGN) Stock: Can It Go Higher?
In the last trading session, 1.3 million shares of the Vistagen Therapeutics Inc (NASDAQ:VTGN) were traded, and its beta was 0.36. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.